Aggressive polychemotherapy may induce prolonged remission in metastatic malignant fibrous histiocytoma.
May support polychemotherapy for durable remission in metastatic MFH; hypothesis-generating and requires prospective validation.
A patient with metastatic malignant fibrous histiocytoma (MFH) achieved a complete remission with polychemotherapy lasting 42+ months. In view of this long-term survival and two similar prior reports of long-term survival after aggressive treatment, the goal of therapy for metastatic MFH must be reconsidered.
No takes yet. Share an insight, caveat, or question.
Clamon et al. (1984) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: